EP Wealth Advisors LLC Purchases 1,231 Shares of Stryker Co. (NYSE:SYK)

EP Wealth Advisors LLC boosted its position in shares of Stryker Co. (NYSE:SYK) by 0.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 180,815 shares of the medical technology company’s stock after buying an additional 1,231 shares during the period. EP Wealth Advisors LLC’s holdings in Stryker were worth $54,147,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Burkett Financial Services LLC bought a new stake in shares of Stryker in the 4th quarter valued at approximately $25,000. Farmers & Merchants Trust Co of Chambersburg PA lifted its stake in shares of Stryker by 203.3% in the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company’s stock valued at $27,000 after purchasing an additional 61 shares during the last quarter. Rogco LP bought a new stake in shares of Stryker in the 4th quarter valued at approximately $30,000. DSM Capital Partners LLC bought a new stake in shares of Stryker in the 4th quarter valued at approximately $34,000. Finally, HBC Financial Services PLLC bought a new stake in shares of Stryker during the 4th quarter worth approximately $37,000. 77.09% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the company. TD Cowen raised their price target on Stryker from $365.00 to $400.00 and gave the stock a “buy” rating in a research note on Thursday, April 11th. The Goldman Sachs Group assumed coverage on Stryker in a research note on Thursday, May 30th. They set a “neutral” rating and a $372.00 price target for the company. Royal Bank of Canada raised their price target on Stryker from $360.00 to $386.00 and gave the stock an “outperform” rating in a research note on Monday, April 15th. Evercore ISI raised their price target on Stryker from $340.00 to $370.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Finally, Robert W. Baird raised their price target on Stryker from $367.00 to $378.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 1st. Four research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $370.58.

Stryker Stock Performance

SYK traded up $1.96 on Friday, reaching $344.98. 746,530 shares of the stock were exchanged, compared to its average volume of 1,214,165. The company’s 50-day moving average price is $336.88 and its 200 day moving average price is $330.15. Stryker Co. has a fifty-two week low of $249.98 and a fifty-two week high of $361.41. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.71 and a quick ratio of 0.99. The firm has a market capitalization of $131.42 billion, a PE ratio of 39.38, a PEG ratio of 2.72 and a beta of 0.92.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Tuesday, April 30th. The medical technology company reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.36 by $0.14. Stryker had a return on equity of 23.05% and a net margin of 16.03%. The company had revenue of $5.24 billion during the quarter, compared to analysts’ expectations of $5.10 billion. During the same quarter in the previous year, the firm posted $2.14 EPS. The firm’s revenue was up 9.7% compared to the same quarter last year. As a group, sell-side analysts forecast that Stryker Co. will post 11.95 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Friday, June 28th will be issued a $0.80 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.20 annualized dividend and a dividend yield of 0.93%. Stryker’s dividend payout ratio (DPR) is presently 36.53%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.